Matias Alvarez-Saavedra, PhD
Expert in Neurobiology, Molecular Biology and Human Genetics – Co-Founder & Chief Scientific Officer, NanoNeurosciences, Inc.
Dr. Alvarez-Saavedra brings advanced expertise in neurodegenerative diseases and cellular biology. His work deciphers the intricate pathways of cell survival and bioenergetics — key to our approach in protecting and restoring vision. With years of cutting-edge research in human molecular genetics and developmental neurobiology, he ensures our therapies target glaucoma at its biological roots.
Senior Research Associate (2021-2024) – Northwestern University, Center for Regenerative Nanomedicine, Chicago, IL, USA
Assistant Professor (2017-2019) – Pontificia Universidad Cátolica de Chile, Department of Cellular & Molecular Biology, Santiago, Chile
Pew Latin American Postdoctoral Fellow (2015-2017) – Department of Biochemistry & Molecular Pharmacology, New York University, NY, USA
Pew Latin American Postdoctoral Fellow (2014-2015) – Diabetes Center, University of California, San Francisco, CA, USA
Ph.D. in Human Molecular Genetics (2013) – University of Ottawa, Cellular & Molecular Medicine Department, Faculty of Medicine, Ottawa, Ontario, Canada
M.Sc. in RNA Biochemistry (2010) – University of Ottawa, Biochemistry, Microbiology & Immunology Department, Faculty of Medicine, Ottawa, Ontario, Canada
Research Assistant (2006 – 2008) – Centro de Estudios Científicos (CECS), Valdivia, Chile
B.Sc. in Molecular Biology (2005) – Montclair State University, Montclair, NJ, USA